This case presents a rare instance of a patient with recurrent ICC who, after undergoing radical surgery, exhibited tumor regression following a comprehensive treatment regimen predominantly featuring targeted therapy, prompted by the detection of an FGFR-2 mutation. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.